Across the US market, the biotin export prices declined steadily during the entire first week of December 2025 supported by a softer global demand and rising international supply. Various market experts considered that this steady drop in biotin export quotations from late November reflected a slowdown in purchasing sentiments ahead of the winter holidays. Overseas buyers in Europe, Southeast Asia, and Latin America showed limited purchasing interest, choosing to delay biotin orders in expectation of additional price easing as the year-ends. The decline was further supported by increased production from other major biotin manufacturers in China and India, whose return to full-capacity operations boosted global availability and intensified price competitions. Moving forward, logistic and currency movements additionally contributed this week’s price drop in biotin: slightly lower ocean freight since november rates reduced landed costs, while despite of stronger US dollar constrained buying power in several emerging markets, supported this week’s weaken trade dynamics. Analysts across the global market further expect prices to continue to remain under pressure through December, with a clearer market direction likely to emerge after holiday-period restocking in early 2026.
As per the market experts, from the us market as December 2025 begins, the export prices for biotin, a key nutritional ingredient widely used across the dietary supplements, food fortification, and pharmaceutical sectors, registered a steady decline. Various industry analysts state the downward trajectory as a cumulative factor of softer international demand, improved global production capacity, and intensified pricing competition from neighboring producing regions.
According to market participants, US export quotations for biotin fell at a steady rate in the first week of December compared to late-November levels with prices showing a drop of 0.43%. Although the decrease is not considered abrupt, the modest day-to-day softening has raised questions about whether the market may be entering a more prolonged period of price pressure after a relatively stable autumn trading cycle.
With respect to the purchasing side, exporters across the US market noted that buying activity from major import destinations, including Latin America, Europe, and South Asian market remained muted throughout the week. Purchasers of biotin reportedly adopted a cautious stance, opting to delay shipments in anticipation of potential further price corrections as the year marks its ending in december. This behavior echoes broader market sentiment in the international vitamins segment, where inventories have remained comfortable and industrial users have shown little inclination to rebuild biotin stocks. As a result, most customers are still well-supplied, and many are planning their procurement cycles around the expectation that biotin prices may fall again before the new year, said one US distributor. That has taken some of the urgency out of the export market.
Supporting to this further, the price decline was also impacted by increasing global biotin output, particularly from other manufacturers across the Asia-pacific. The improved supply environment in other regions has also narrowed the pricing gap between US and Asian producers, contributing to competitive undercutting in key export-oriented nations, particularly the China and India. Market analysts note that while the US retains strong positioning in high-purity and specialty biotin categories, more price-sensitive segments for biotin remain vulnerable to fluctuations driven by Asian production trends as well.
Supporting the fact and beyond supply-demand fundamentals, logistics and currency dynamics also continue to play a subtle but notable role in pricing shifts. Ocean freight rates on several trans-Pacific and trans-Atlantic routes continue to ease slightly since November, lowering landed cost estimates for biotin overseas buyers. Meanwhile, a modest strengthening of the US dollar against several emerging-market currencies further reduces the purchasing activity in importing regions, amplifying downward price pressure on the supplies of biotin.
Looking ahead, market considers that biotin export prices are likely to remain under pressure through the remainder of December, although a sharp downturn is not anticipated. Many exporters owing to this, are preparing to manage their trading volumes until after the holiday period, in order to prevent further stockpiling resulting in an higher storage cost and the concern about product damage.
Analysts state that the medium-term outlook will depend on global manufacturing rates, consumer demand trends, and the broader macro-economic environment. For now, the early-December decline depicts a clear sign that the biotin market has shifted to a more supply-sufficient factor, rather than buyer-driven phase as 2025 draws to a close.
